Pfizer asks FDA to expand emergency use of its COVID-19 vaccines to includes kids from ages 12 to 15

BREAKING NEWS: Pfizer asks FDA to expand emergency use of its COVID-19 vaccine to include kids ages 12 to 15

  • Pfizer Inc has asked the FDA to expand emergency use of its COVID-19 vaccine to Americans between ages 12 and 15 years old
  • Recent clinical trial data found that the vaccine was 100 percent safe and effective in younger teens
  • If approved by the FDA, 12-to-15 year olds could be immunized before the start of the 2021 school year 

Pfizer Inc has asked the U.S. Food and Drug Administration (FDA) to expand emergency use of its COVID-19 vaccine to Americans between ages 12 and 15 years old. 

When the vaccine was originally authorize for use by the FDA in December 2020, it was for those aged 16 and older. 

But recently Phase III clinical trial data found that the vaccine was 100 percent safe and effective in younger teens.

If approved by the FDA, 12-to-15 year olds could be immunized before the start of the 2021 school year. 

Pfizer Inc has asked the FDA to expand emergency use of its COVID-19 vaccine to Americans between ages 12 and 15 years old (file image)

This is a breaking news story and will be updated.